{
    "Trade/Device Name(s)": [
        "CLINITEK Advantus TM"
    ],
    "Submitter Information": "Bayer HealthCare, LLC",
    "510(k) Number": "K063276",
    "Predicate Device Reference 510(k) Number(s)": [
        "K926359"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JIL",
        "JIO",
        "JFY",
        "JJB",
        "JIN",
        "LJX",
        "JMT",
        "CEN",
        "JIR",
        "JRE",
        "CDM",
        "KQO"
    ],
    "Summary Letter Date": "October 26, 2006",
    "Summary Letter Received Date": "October 30, 2006",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.2900",
        "21 CFR 862.1340"
    ],
    "Regulation Name(s)": [
        "Automated urinalysis system",
        "Urinary glucose (nonquantitative) test system"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "toxicology"
    ],
    "Analyte(s)": [
        "Bilirubin",
        "Blood (Occult)",
        "Creatinine",
        "Glucose",
        "Ketone",
        "Leukocytes",
        "Nitrite",
        "pH",
        "Protein",
        "Protein-to-Creatinine Ratio",
        "Specific Gravity",
        "Urobilinogen"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "CLINITEK Advantus TM"
    ],
    "Method(s)/Technology(ies)": [
        "Reflectance spectrophotometry"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Analyzer"
    ],
    "Document Summary": "FDA 510(k) summary for CLINITEK Advantus TM semi-automated urine chemistry analyzer using reflectance spectrophotometry for in vitro diagnostic testing.",
    "Indications for Use Summary": "Intended for measurement of multiple urine analytes to assist diagnosis of kidney function, urinary tract infections, metabolic disorders, and liver function, using Bayer reagent strips in a semi-automated benchtop analyzer for in vitro diagnostic use.",
    "fda_folder": "Clinical Chemistry"
}